{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:23:59Z","timestamp":1787765039329,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with polycystic ovarian syndrome (PCOS) have unique characteristics depending on its phenotype. Therefore, prediction of controlled ovarian stimulation (COS) response and assisted reproductive technique (ART) outcome in these becomes challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To assess the outcomes of assisted reproductive technology (ART) in various polycystic ovary syndrome (PCOS) phenotypes and to evaluate the predictive value of anti-Mullerian hormone (AMH) and total testosterone on ART success. Clinical pregnancy rate (CPR) was measured as the primary outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This was a prospective observational study conducted at a tertiary care centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of 190 infertile women with PCOS (Rotterdam criteria) were enrolled and were subdivided into four phenotypes. Baseline screening and transvaginal scan were done. All patients underwent COS using antagonist protocol with recombinant follicle-stimulating hormone, and an agonist trigger was given for follicular maturation. One or two blastocysts were transferred in a frozen\u2013thawed embryo transfer cycle. Luteal phase support was given with vaginal progesterone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>For quantitative variables, we employed the Kruskal-Wallis Test with post hoc Tukey\u2019s analysis. For continuous or ordinal variables, the Mann-Whitney U test was utilized. The analysis of categorical data was conducted using the Chi-square (\u03c72) test with SPSS 21 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Phenotype A was the most prevalent (37%). CPR was the highest in phenotype D (57.7%), followed by phenotype C (53.06%), A (43%) and B (36%). The mean serum AMH level was the highest in phenotype A (9.7 \u00b1 4.3 ng\/dL) and the lowest in phenotype B (5.9 \u00b1 1.8 ng\/dL). The mean total testosterone level was 103 \u00b1 15.68 ng\/mL in Type A, 109.46 \u00b1 37.08 ng\/mL in Type B and 48.52 \u00b1 17.07 ng\/ml in Type D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Phenotype D showed higher CPR and lower miscarriage rate compared to other phenotypes (not significant) and was associated with good clinical outcome. No correlation could be established with serum AMH, total testosterone levels and CPR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_145_23","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T19:00:06Z","timestamp":1703876406000},"page":"340-345","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Comparing Assisted Reproductive Outcomes in Women with Different Polycystic Ovary Syndrome Phenotypes Undergoing Frozen Embryo Transfer"],"prefix":"10.4103","volume":"16","author":[{"given":"Anubhuti","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Milann Fertility Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anviti","family":"Saraf","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Milann Fertility Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyshnavi A.","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Milann Fertility Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini A.","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Milann Fertility Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"R1-20240905","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"R2-20240905","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: A brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J Hum Reprod Sci"},{"key":"R3-20240905","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: Approach to clinical practice","volume":"70","author":"Melo","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"R4-20240905","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fertnstert.2016.05.011","article-title":"Environmental determinants of polycystic ovary syndrome","volume":"106","author":"Merkin","year":"2016","journal-title":"Fertil Steril"},{"key":"R5-20240905","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J Endocr Soc"},{"key":"R6-20240905","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10815-013-0149-0","article-title":"Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms","volume":"31","author":"Sahmay","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"R7-20240905","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/cen.13269","article-title":"Anti-M\u00fcllerian hormone reflects the severity of polycystic ovary syndrome","volume":"86","author":"Jacob","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"R8-20240905","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.fertnstert.2006.04.011","article-title":"Insulin resistance in women with polycystic ovary syndrome","volume":"86","author":"Dunaif","year":"2006","journal-title":"Fertil Steril"},{"key":"R9-20240905","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: A systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"key":"R10-20240905","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: A review","volume":"20","author":"Ashraf","year":"2019","journal-title":"Egypt J Med Hum Genet"},{"key":"R11-20240905","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/en.2016-1801","article-title":"Gestational hyperandrogenism in developmental programming","volume":"158","author":"Hakim","year":"2017","journal-title":"Endocrinology"},{"key":"R12-20240905","doi-asserted-by":"crossref","first-page":"735684","DOI":"10.3389\/fcell.2021.735684","article-title":"Molecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and cumulus cells","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R13-20240905","first-page":"125","article-title":"Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls","volume":"1","author":"Chappell","year":"2020","journal-title":"F S Rep"},{"key":"R14-20240905","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R15-20240905","doi-asserted-by":"crossref","first-page":"hoy021","DOI":"10.1093\/hropen\/hoy021","article-title":"Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Assessment and treatment of infertility","volume":"2019","author":"Costello","year":"2019","journal-title":"Hum Reprod Open"},{"key":"R16-20240905","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"The Istanbul consensus workshop on embryo assessment: Proceedings of an expert meeting","volume":"26","year":"2011","journal-title":"Hum Reprod"},{"key":"R17-20240905","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2013.05.019","article-title":"Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome","volume":"170","author":"Sahmay","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R18-20240905","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.rbmo.2016.01.010","article-title":"Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: The predictive value of anti-M\u00fcllerian hormone","volume":"32","author":"Ramezanali","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"R19-20240905","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/09513590.2019.1613640","article-title":"Correlation of body mass index (BMI), anti-Mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes \u2013 A cross-sectional study","volume":"35","author":"Gupta","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"R20-20240905","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/j.fertnstert.2020.08.1181","article-title":"Does controlled ovarian hyperstimulation response varies with pcos phenotypes: a prospective cohort study at a tertiary infertility centre in INDIA","volume":"114","author":"Nayar","year":"2020","journal-title":"Fertility and Sterility"},{"key":"R21-20240905","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2018.03.007","article-title":"Serum AMH levels and insulin resistance in women with PCOS","volume":"224","author":"Sahmay","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R22-20240905","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/nu12071953","article-title":"Obesity, insulin resistance, and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women","volume":"12","author":"Kazemi","year":"2020","journal-title":"Nutrients"},{"key":"R23-20240905","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7555\/JBR.30.20140111","article-title":"Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: A prospective study","volume":"30","author":"Yuan","year":"2016","journal-title":"J Biomed Res"},{"key":"R24-20240905","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13098-015-0040-5","article-title":"The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women","volume":"7","author":"Valderhaug","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"R25-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/tjod.90094","article-title":"Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome","volume":"13","author":"Sel\u00e7uk","year":"2016","journal-title":"Turk J Obstet Gynecol"},{"key":"R26-20240905","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ijgo.12707","article-title":"Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes","volume":"144","author":"Eftekhar","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R27-20240905","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.rbmo.2018.05.003","article-title":"Cumulative live birth rates after IVF in patients with polycystic ovaries: Phenotype matters","volume":"37","author":"De Vos","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"R28-20240905","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/REP-15-0044","article-title":"Follicular hyperandrogenism downregulates aromatase in luteinized granulosa cells in polycystic ovary syndrome women","volume":"150","author":"Yang","year":"2015","journal-title":"Reproduction"},{"key":"R29-20240905","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.rbmo.2013.11.017","article-title":"Impact of PCOS on early embryo cleavage kinetics","volume":"28","author":"Wissing","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"R30-20240905","doi-asserted-by":"crossref","first-page":"108989","DOI":"10.1016\/j.steroids.2022.108989","article-title":"Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome","volume":"180","author":"Chappell","year":"2022","journal-title":"Steroids"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_145_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:58:00Z","timestamp":1787763480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_145_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_145_23","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-10-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}